skip to primary navigationskip to content
 

Camallergy Appoints Baxter Phillips III as CEO

last modified Oct 25, 2018 01:48 PM
Camallergy, based at ideaSpace South, a biopharmaceutical company dedicated to providing patient-centric treatments for life-threatening food allergies, has announced the appointment of Baxter Phillips III as Chief Executive Officer. Camallergy co-founder Sherden Timmins continues his executive appointment in the newly created role of Chief Operating Officer.

Baxter comes to Camallergy with first-hand knowledge of patient well-being for those who suffer from food allergies. Coupled with a strategic executive’s vision of how to build and deliver on our mission to bring the best treatment for patients to market, we believe he is an exceptional addition to our team at Camallergy as we advance into Phase 3 trials,” stated Dr. Jonathan Milner, PhD, Chairman of the Camallergy Board of Directors and co-founder of Abcam. 

Commenting on his appointment Mr. Phillips said: “With life-threatening food allergies in my family, specifically peanut allergy, I have spent the last several years evaluating current treatment options as well as the various treatments in development today. I am thrilled and privileged to join this pioneering team at Camallergy who is developing what I believe to be the most therapeutically attractive solution for peanut allergy patients."

Read the full article here.

RSS Feed Latest news

GeoSpock Lands £10 Million in Additional Funding 

Jan 09, 2019

ideaSpace alumni and extreme data specialists, GeoSpock, have secured an extra  £10 million in funding. The latest round was led by Cambridge Innovation Capital (CIC) jointly with Parkwalk Advisors and Japanese firms Global Brain and 31Ventures. Japanese data tech company KDDI Supership joined as a strategic investor. Investment was also secured from existing investor, Jonathan Milner.

A Breath Test Could Detect Early Cancer Signs

Jan 06, 2019

CRUK and ideaSpace City members, Owlstone Medical, have launched a new trial to discover whether it's possible to detect early stage cancer symptoms from a person's breath.

Petagene secure $2.1 Million in Funding 

Jan 03, 2019

2019 is off to a great start for the Petagene team who have been awarded $2.1 million in additional funding. The latest round was lead by U.S. venture firm Romulus Capital, with collaboration from other unnamed investors in London and Silicon Valley, bringing the total funding awarded to $3.2 million.

LESSONS FOR A FOUNDER: Your Fundraising Questions Answered

Dec 20, 2018

Are you going to be fundraising for your startup in 2019? The landscape of startup funding can seem bewildering. So we asked experienced fundraising coach, Jonathan Leinmuller, to share his knowledge about how best to raise capital. Here’s what he had to say...

C1209 Selected as a Startup With High Potential for International Scale

Dec 14, 2018

ideaSpace City members C1209 have been selected by Virgin as a startup with high potential for international scale, as part of the Virgin StartUp StepUp programme. This follows on from a recent feature in British Vogue which named C1209's Franklin bag as 'One of the Best Office Bags For Women'. 

View all news